Literature DB >> 25207035

Kinetic analysis of the amino terminal end of active site loop of lactate deyhdrogenase from Plasmodium vivax.

Ozal Mutlu1, Dilek Turgut Balık2.   

Abstract

OBJECTIVE: In this study, kinetic analysis was performed to understand the functional importance of the amino terminal of the active site of previously mutated Plasmodium vivax Lactate Dehydrogenase enzyme by mimicking Toxoplasma gondii I, II, Eimeria acervulina and Eimeria tenella LDH's.
MATERIAL AND METHODS: Mutant LDH genes were amplified by PCR and 6xHistag was added to the C-terminal of the enzymes. Then LDH enzymes are overproduced as recombinant in E. coli cells, purified by Ni-NTA agarose matrix and kinetic properties were analysed.
RESULTS: Observing increase of Km values of mutant enzymes showed that mutations in this place caused decreasing affinity of enzyme for its substrate. However kcat values were about the same throughout all mutant proteins.
CONCLUSION: Sensitivity of the studied region emphasizes the significance of this site for drug design studies for both Plasmodium and some other Apicomplexans.

Entities:  

Keywords:  Lactate dehydrogenase; Plasmodium vivax; antimalarial drug; kinetic analysis; site-directed mutagenesis

Year:  2012        PMID: 25207035      PMCID: PMC4115892          DOI: 10.5152/balkanmedj.2012.047

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  14 in total

1.  Overcoming cloning problems by staining agarose gels with crystal violet instead of ethidium bromide in lactate dehydrogenase gene from Plasmodium vivax and Plasmodium falciparum.

Authors:  D Turgut-Balik; V C Celik; Kath Moreton; R L Brady
Journal:  Acta Biol Hung       Date:  2005

Review 2.  Chloroquine resistance in Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 3.  New antimalarial targets: the example of glucose transport.

Authors:  Asha Parbhu Patel; Henry M Staines; Sanjeev Krishna
Journal:  Travel Med Infect Dis       Date:  2008-03-07       Impact factor: 6.211

4.  Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening.

Authors:  Janet Cox-Singh; Timothy M E Davis; Kim-Sung Lee; Sunita S G Shamsul; Asmad Matusop; Shanmuga Ratnam; Hasan A Rahman; David J Conway; Balbir Singh
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

5.  The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design.

Authors:  C R Dunn; M J Banfield; J J Barker; C W Higham; K M Moreton; D Turgut-Balik; R L Brady; J J Holbrook
Journal:  Nat Struct Biol       Date:  1996-11

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles.

Authors:  R E Royer; L M Deck; N M Campos; L A Hunsaker; D L Vander Jagt
Journal:  J Med Chem       Date:  1986-09       Impact factor: 7.446

8.  Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum.

Authors:  M S Gomez; R C Piper; L A Hunsaker; R E Royer; L M Deck; M T Makler; D L Vander Jagt
Journal:  Mol Biochem Parasitol       Date:  1997-12-01       Impact factor: 1.759

9.  Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay.

Authors:  L K Basco; F Marquet; M M Makler; J Le Bras
Journal:  Exp Parasitol       Date:  1995-03       Impact factor: 2.011

10.  Plasmodium falciparum: enhanced soluble expression, purification and biochemical characterization of lactate dehydrogenase.

Authors:  Ritu Berwal; Natarajan Gopalan; Kshitij Chandel; G B K S Prasad; Shri Prakash
Journal:  Exp Parasitol       Date:  2008-06-21       Impact factor: 2.011

View more
  1 in total

1.  Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study.

Authors:  Diana Nabrdalik-Leśniak; Katarzyna Nabrdalik; Katarzyna Sedlaczek; Patryk Główczyński; Hanna Kwiendacz; Tomasz Sawczyn; Weronika Hajzler; Karolina Drożdż; Mirela Hendel; Krzysztof Irlik; Paweł Stelmach; Piotr Adamczyk; Andrzej Paradysz; Sławomir Kasperczyk; Tomasz Stompór; Janusz Gumprecht
Journal:  Oxid Med Cell Longev       Date:  2021-07-14       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.